Dr. Yaozhu Wang, Anesthesia Insomnia Clinic, Department ofAnesthesiology Outpatient Clinic, Shandong Second Provincial General Hospital, Jinan, People’s Republic ofChina. Specialized in clinical anesthesia and therapeutic practices, as well as medical innovation and translational research, with expertise in otolaryngological anesthesia, non -pharmacological treatment of insomnia disorders, migraines, primary dysmenorrhea, functional gastrointestinal disorders, and allergic rhinitis.

Proponent of the “Multi-level Combination Therapy Concept” (MCTC), proficient in utilizing MCTC for precise management of myofascial trigger points, ultrasound-guided stellate ganglion block, and radiofrequency modulation therapy. Skilled in ultrasound-guided sphenopalatine ganglion block therapy.Principal investigator of one provincial-level research project, author of 6 SCI-indexed publications, and 7 core Chinese journal articles. Holder of2 national invention patents and over 30 national utility model patents, with more than 10 authorized.Certified as an Intermediate Technology Manager in the biomedical field by the Ministry of Science and Technology ofChina and Shandong Province.Recipient of the Best Researcher Award at the 14th Global Innovation Technologist Awards (INT 2025) in Medicine and Health Sciences.

Dr. Ekaansh Karir is an orthopaedic surgery resident in Government Medical College, Kota, Rajasthan, India. He did his
MBBS from Shri B M Patil Medical College, Vijayapura, Karnataka, India and is also a certified ATLS Instructor certified by
the ATLS (USA) Organization. He has published 10+ research papers in various indexed journals and presented 10+
papers at various national conferences throughout the country and is a gold medallist among many other coveted laurels for
his papers. He is an avid researcher and a surgeon and has special interest in Spine, Trauma and Arthroplasty

Dr. Qin is a professor at the Icahn School of Medicine at Mount Sinai & James J. Peters Veteran Affairs Medical Center, based in New York City. Dr. Qin received his M.D. degree from Fujian Medical University, China, and his Ph.D. degree from Kanazawa University, Japan. Dr. Qin is a recognized authority on studying neuromusculoskeletal disorders after spinal cord injury (SCI). Since 2007, Dr. Qin has evaluated mechanisms of bone loss after SCI and has developed pharmacological interventions to block bone loss or restore bone mass after SCI. More recently, Dr. Qin has developed a novel cutting-edge nanomedicine approach for drug-targeted delivery as more efficacious and safer method to provide neuroprotection and functional recovery in acute SCI.  Dr. Qin recently also discovered a novel mechanism of muscle-bone crosstalk in maintaining homeostasis of the local musculoskeletal environment through osteocytes by the generation and release of microRNAs from extracellular microvesicle-exosomes.

Dr. Kazuo Ando is an anesthesiologist and clinical scientist affiliated with Stanford University School of Medicine. With expertise in the fields of anesthesia and clinical research, Dr. Ando has likely made significant contributions to the medical community, particularly in advancing patient care through innovative anesthesia techniques or research. His work involves bridging the gap between scientific discovery and clinical application, aiming to improve the safety, efficacy, and outcomes of anesthesia in medical procedures.

Given that Dr. Ando holds a position at one of the leading institutions in the world, his research could span a variety of areas, from anesthetic drug development to understanding patient responses during surgeries or other medical treatments. His focus may also include improving the technology and methods used in anesthesiology to make them safer and more effective.

Dr. Kyle Kim, currently a surgical service registrar in Bunbury, WA, completed his medical training at the University of Western Australia in 2017. With a knack for navigating the complexities of the upper gastrointestinal tract, he’s not just skilled with a scalpel—he’s also known for his keen interest in UGI surgery, making him the go-to expert when things get a bit ‘stomach-churning’.

Alexey Fedoruk MD, PhD, D.Sc., was born on December 25, 1957 in Brest, USSR. In 1983 he graduated from the Minsk State Medical Institute with a degree in general medicine. Professor of Clinical Medicine, Honored Doctor of the Republic of Belarus, Head of Department (surgeon) Department of Hepatology and Minimally Invasive Surgery, Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology. The main area of ​​work is devoted to the diagnosis and treatment of complications after high-tech operations and transplantation of solid organs.     Has academic degrees in gastroenterology, surgery and radiology. Author of 19 inventions, 17 patents, 7 monographs, 3 teaching aids and more than 250 published works.     Successfully combines practical medical activities with scientific and pedagogical work – professor of the Department of Surgery and Transplantology of the Belarusian State Medical University.

Abstract:
Although hospital presentations from kangaroo-related injuries commonly stem from motor vehicle collisions, a lesser-known subset involves assaults by kangaroos. In an Australian study over 10 years, only 40 attacks on humans were reported ¹. The rate of human injury from kangaroos has speculatively increased, attributed to changes in its natural habitat from fires and urbanisation ².  We present the case of a 75-year-old gentleman who sustained multiple injuries, including a scrotal tear and hemopneumothorax, from a kangaroo-related assault. This case highlights the diverse nature of kangaroo-related injuries and underscores the need for public safety campaigns and comprehensive reporting mechanisms to capture injury rates from incidents involving kangaroos, especially in the setting of climate change-altering environments and increasing human-wildlife contact.
Biography:
Dr Chloe Price  is an Indigenous Australian hailing from various regions across Western Australia. After completing medical school at the University of Notre Dame Fremantle, she developed a passion for General Surgery. She now resides in Bunbury, where she continues to pursue her surgical career amidst the unique challenge of avoiding kangaroo encounters in the Australian outback.

Dawn E. Jaroszewski, M.D., is a Professor in the Department of Cardiothoracic Surgery at Mayo Clinic in Arizona. She joined the staff of Mayo Clinic in 2006 and is the former Chair of Thoracic Surgery. She currently serves as the Director of the Mayo Clinic Chest Wall and Thoracic Surgery Program, which has become one of the largest volume adult pectus treatment sites in North America.

Dr. Jaroszewski earned her B.A. and MBA from the University of Texas and her medical degree from the University of Texas Health Science Center at San Antonio. She trained at Mayo Clinic in general surgery and at Baylor College of Medicine/MD Anderson in cardiothoracic surgery. She further completed an advanced chest fellowship at the University of California Los Angeles.

Double-boarded in both cardiothoracic and general surgery, Dr. Jaroszewski is a fellow of the American College of Surgeons. She is an active member in the Society of Thoracic Surgeons and president elect of the Chest Wall International Group. She is an investigator for the National Institutes of Health and National Cancer Institute and an Esophageal and Gastric Cancer guideline panel member for the National Comprehensive Cancer Network.

Dr. Jaroszewski specialized in pectus and chest wall deformities and has performed over 1,300 cases. She has been involved in over 100 research projects and publications of peer-reviewed journal articles and book chapters and presents internationally on her expertise

Hiroko Ochiai is the Chief of the Department of Plastic Surgery and Director of the Breast Reconstruction Center at the National Hospital Organization Tokyo Medical Center. With specialized expertise in post-malignant tumor resection reconstruction and ptosis surgery, Dr. Ochiai collaborates with various departments to provide comprehensive care for patients. She is deeply committed to educating and mentoring young physicians and nurses, fostering the development of the next generation of healthcare professionals.

In addition to her clinical responsibilities, Dr. Ochiai leads groundbreaking research on wound healing as the Director of the Regenerative Medicine Research Laboratory. Her work in regenerative medicine is at the forefront of advancing patient care. As a certified forest medicine specialist, Dr. Ochiai is a passionate advocate for the health benefits of forests, integrating this knowledge into her practice to promote both physical and mental well-being.